Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

| More on:
Six smiling health workers pose for a selfie.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sigma Healthcare Ltd (ASX: SIG) shares have been on a tear this past year.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock – which owns chemists including Amcal, Discount Drug Stores, and Guardian Pharmacy – really took off a bit over a year ago, in December 2023.

That's when Sigma first announced its $30 billion merger intentions with privately owned Chemist Warehouse.

As those merger plans progressed throughout 2024 and into 2025, Sigma shares made some ASX investors very happy.

How happy?

Let's have a look.

What $5,000 invested in Sigma shares last December is worth today

If you had a working time machine, you could pop back to 1 December 2023 and snap up Sigma shares for 69 cents apiece.

This means your $5,000 investment would have netted you 7,246 shares (ignoring brokerage fees).

In late afternoon trade today, those same shares are changing hands for $2.75 apiece.

That means the Sigma shares you bought on 1 December 2023 for $5,000, less than 15 months ago mind you, is now worth a whopping $19,926.50. Or a gain of 298.6%.

But we're not quite done with the maths yet.

Adding a little icing to this highly profitable cake, you'd also have received a total of 1 cent per share in partly franked dividends over this period.

Which would bring your total returns on the initial $5,000 investment to $19,998.96.

Now, when you're done with the time machine, can you please drop it by my office!

What's the latest on the pending merger with Chemist Warehouse?

On 30 January, ASX 200 investors learned that, as expected, Sigma shareholders had voted to approve the merger with Chemist Warehouse, with 99.86% voting 'yes'.

Sigma shareholders also agreed to elect four Chemist Warehouse executives to the Sigma board.

The Chemist Warehouse board's vote to approve the merger received 99.23% support.

Commenting on the merger on the day, Sigma chair Michael Sammells said:

Sigma has world-class distribution infrastructure and capability that is delivering best in class service to pharmacies across Australia every day.

Chemist Warehouse has unparalleled pharmacy franchise and marketing know-how and expertise which will also help elevate our support for our Amcal and Discount Drug Store franchisees.

Given the nature and value accretion of the proposed transaction, Sigma Directors unanimously recommend that shareholders vote in favour of the resolutions.

Sigma shares had been in a trading halt the day before and closed down 3.6% following the news.

Though, as we saw above, that hardly crimped the returns investors have reaped since the merger news first broke in December 2023.

The merger process was finalised this afternoon when Sigma announced that its 100% acquisition of issued shares in Chemist Warehouse via a scheme of arrangement was implemented today.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man looking happy and excited as he looks at his mobile phone.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on big news

This stock is getting a lot of attention from investors on Wednesday. But why?

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Healthcare Shares

How much further upside is there for Mesoblast shares after soaring 23% in a month?

Could FDA approval send this healthcare stock towards further gains?

Read more »

woman in lab coat conducting testing representing biotech
Healthcare Shares

Is this soaring ASX 200 healthcare share just getting started?

If its lead therapy gets US approval, the stock can continue to climb.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Own CSL shares? Here are the key dates for 2026

It's been a bad year for CSL shares. What's ahead in 2026?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Healthcare Shares

Is Sigma Healthcare share a healthy buy, after hitting new lows?

The Chemist Warehouse merger and ageing population might boost this stock's appeal.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Telix shares fall despite 'significant milestone'

Let's see what the biotech has announced on Monday.

Read more »